# To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.

> **NCT00763360** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 184 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** DisCoVisc®
- **DRUG:** Healon
- **DRUG:** Amvisc Plus

## Key facts

- **NCT ID:** NCT00763360
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-09
- **Final completion:** —
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2012-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763360, "To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00763360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*